Versartis (NASDAQ:VSAR) Stock Sentiment Increases to 0.67

Versartis’s Sentiment

In Q2 2018 Versartis (NASDAQ:VSAR) big money sentiment increased to 0.67, according to SEC filings. So its up 0.17, from 2018Q1’s 0.5. 29 funds increased and opened new positions, while 43 decreased and sold stakes in Versartis so the sentiment is more positive. Funds own 12.82 million shares, down from 13.21 million shares in 2018Q1. Funds holding Versartis in top 10 increased from 0 to 1 for an increase of 1. 25 Investors Sold All; 18 Reduced Holdings; 13 increased stakes while 16 funds bought stakes.

Significant Versartis Investors

As of Q2 2018 New Leaf Venture Partners L.L.C. has 1.1% invested in Versartis. As of Q2 2018, 248,653 shares of Versartis are owned by Sio Capital Management Llc. Also, Sabby Management Llc reported 220,600 shares in Versartis equivalent to 0.07% of its equity exposure. The California-based fund Ascend Capital Llc have invested about 0.06% of the active investment manager’s stock portfolio in Versartis. The New York-based fund Baker Bros. Advisors Lp looks positive on Versartis, owning 2.43 million shares.

Versartis, Inc. operates as an endocrine-focused biopharmaceutical firm in the United States.The company has $43.13 million market cap. The firm is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase III clinical trials for the treatment of growth hormone deficiency.Currently it has negative earnings. It develops drug candidates that it has licensed from Amunix Operating, Inc.

The stock decreased 1.65% or $0.02 during the last trading session, hitting $1.19.Versartis, Inc. has 343,897 shares volume, 31.41% up from normal. VSAR is downtrending and has moved 91.55% since December 8, 2017. VSAR underperformed the S&P500 by 107.17%.

Morgan Stanley has 233,458 shs. Moreover, Acadian Asset Mngmt Ltd Liability Corporation has 0% invested in Versartis, Inc. (NASDAQ:VSAR) for 83,064 shs. Royal Retail Bank Of Canada holds 7,030 shs or 0% of its capital. Sio Capital Mgmt Ltd owns 248,653 shs. Northern holds 0% of its capital in Versartis, Inc. (NASDAQ:VSAR) for 82,803 shs. Bank Of Montreal Can accumulated 101 shs. 36,671 are held by Walleye Trading Limited Liability. Susquehanna Group Inc Llp reported 81,002 shs. National Bank & Trust Of America De holds 0% or 42,189 shs in its capital. Gp One Trading Limited Partnership stated it has 32,200 shs or 0% of all its holdings. Hrt Financial Lc invested in 14,823 shs or 0.01% of the stock. Barclays Public Ltd accumulated 46,881 shs or 0% of the stock. 4,460 were accumulated by Wells Fargo & Company Mn. Moreover, Vanguard Gp Incorporated has 0% invested in Versartis, Inc. (NASDAQ:VSAR). Goldman Sachs Gp reported 0% stake.

Versartis, Inc. registered $111,191 net activity with 1 buy and 2 insider sales since June 6, 2018. $329 worth of stock was sold by Haas Kevin on Friday, June 15. Westberg Paul sold $1,408 worth of stock.

For more Versartis, Inc. (NASDAQ:VSAR) news brought out recently go to: Seekingalpha.com, Seekingalpha.com, Fool.com, Seekingalpha.com or Globenewswire.com. The titles are as follows: “Biotech Forum Daily Digest: Another Drug Approval For Aratana, Sorrento Makes Some Moves, Spotlight On Versartis – Seeking Alpha” brought out on August 17, 2016, “Institutional Top Ideas Series: Perceptive Advisors – Seeking Alpha” on May 24, 2018, “This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4% – The Motley Fool” with a publish date: September 22, 2017, “Institutional Top Ideas: EcoR1 Capital – Seeking Alpha” and the last “Annual Changes to the NASDAQ Biotechnology Index – GlobeNewswire” with publication date: December 08, 2017.

Versartis, Inc. (NASDAQ:VSAR) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.